Outset Medical Inc (OM)
3.85
-0.06
(-1.53%)
USD |
NASDAQ |
Jun 14, 16:00
3.85
0.00 (0.00%)
Pre-Market: 20:00
Outset Medical Research and Development Expense (TTM): 56.15M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 56.15M |
| December 31, 2023 | 57.31M |
| September 30, 2023 | 56.22M |
| June 30, 2023 | 53.20M |
| March 31, 2023 | 51.82M |
| December 31, 2022 | 48.86M |
| September 30, 2022 | 48.82M |
| June 30, 2022 | 45.49M |
| Date | Value |
|---|---|
| March 31, 2022 | 40.00M |
| December 31, 2021 | 36.74M |
| September 30, 2021 | 33.12M |
| June 30, 2021 | 32.56M |
| March 31, 2021 | 30.58M |
| December 31, 2020 | 28.85M |
| September 30, 2020 | 27.70M |
| June 30, 2020 | 24.23M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
24.23M
Minimum
Jun 2020
57.31M
Maximum
Dec 2023
41.98M
Average
42.75M
Median
Research and Development Expense (TTM) Benchmarks
| AngioDynamics Inc | 32.65M |
| Baxter International Inc | 679.00M |
| Allurion Technologies Inc | 25.57M |
| Perspective Therapeutics Inc | 24.91M |
| Xtant Medical Holdings Inc | 1.689M |